Anavex Reports Positive 4-Year Blarcamesine Alzheimer’s Data
July 31, 2025
New clinical Precision Medicine population data demonstrates up to 84.6 Weeks (19.5 Months) ‘time saved’ by early-start Anavex Life Sciences Corp. , a clinical-stage biopharmaceutical